Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase III placebo-controlled comparative study of SJP-0118 in patients with bacterial conjunctivitis

Trial Profile

A phase III placebo-controlled comparative study of SJP-0118 in patients with bacterial conjunctivitis

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Oct 2018

At a glance

  • Drugs SJP 0118 (Primary)
  • Indications Conjunctivitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Senju Pharmaceutical
  • Most Recent Events

    • 18 Oct 2018 Status changed from active, no longer recruiting to completed.
    • 18 Apr 2018 Status changed from recruiting to active, no longer recruiting.
    • 28 Jul 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top